Create a free Feed Strategy account to continue reading

Merger of Advent International, Wilbur-Ellis units complete

Advent International and Wilbur-Ellis have completed a deal to merge their life sciences and specialty chemicals solutions businesses, Caldic B.V. and Connell.

Life sciences and specialty chemicals businesses, Caldic and Connell, join forces

Advent International and Wilbur-Ellis have completed a deal to merge their life sciences and specialty chemicals solutions businesses, Caldic B.V. and Connell. The merger was announced in October 2022.

Caldic, a global provider of specialty ingredients and chemicals for the life sciences and industrial formulation markets with a major presence in Europe, North America and Latin America, will benefit by increasing its global presence through a merger with Connell, which is one of the major players in Asia-Pacific.

“The significant global footprint provides unique opportunities to create value for both principals and customers and will drive investments in people, technical expertise and application centers, as well as manufacturing and warehousing sites to support the delivery of innovative and sustainable solutions,” Caldic said in a press release.

The Asia-Pacific region will operate under the Connell Caldic brand.

“The global scale of our business will unlock multiple opportunities to create value with our business partners,” said Alexander Wessels, Group CEO. “Today’s worldwide reach will make our offering of unique value-added services and products more widely accessible to the food and nutrition, (bio)pharma, personal care and industrial formulation markets, which will fuel new business development potential across the supply chain. Our ambition is to redefine the parameters of added value in the ingredients and specialty chemicals distribution sector, offering our customers a new standard in customized solutions.”

Together, Caldic and Connell will have more than 3,800 employees across 43 countries, which provide solutions to more than 35,000 customers by leveraging 75 formulation centers and application labs and deep application know-how. The combination will generate sales of about EUR3 billion (US$2.92 billion).

“Our customers are increasingly demanding customized solutions and extended supply chain services,” said Azita Owlia, CEO of Connell Caldic APAC. “We are committed to leverage the complementarity and synergies between both companies’ value-added product portfolio and broader manufacturing and distribution facilities, to the benefit of our principals and customers. Asia-Pacific is a high-growth region with tremendous potential and the joint expertise and capabilities will allow us to help our current and new customers to seize such opportunities. Together we can make a much bigger positive impact in the life sciences and material sciences markets.”

Page 1 of 180
Next Page